Michael Wiley, Chief Operating Officer, has an extensive professional history in health care and biotech.

Michael Wiley, prior to joining Culmination as Chief Operating Officer, incorporated and co-founded Guardant Health and helped build it from 2012 to 2022.

At Guardant, in addition to his post as Chief Legal Officer through almost all of his tenure, Michael led finance, accounting, HR, reimbursement, and international commercialization amongst other responsibilities for a number of years during Guardant’s rapid growth, including over $500M in pre-IPO financing and over $2B in IPO and post-IPO offerings, initial commercialization of multiple complex products and overall company revenue growth to almost $500M per annum and employee growth to more than 1,700 current employees.

Prior to Guardant and after working as a tax accountant at KPMG and an attorney at Venture Law Group, Michael played senior executive roles at IntegenX (sold to ThermoFisher), Avantome (sold to Illumina), Voyage Medical (sold to Intuitive Surgical) and Farapulse (sold to Boston Scientific).

Michael is married with four children that keep him busy outside his work responsibilities; he also enjoys skiing (water and snow), various team sports (coaching and playing), and playing in the beautiful outdoors of Utah.